Abstract |
The closed enriched cross maze test was employed as a new experimental model of the attention deficit disorder (ADD) for evaluation of the behavioral and neurochemical effects of the nootropic drug pantogam (100 mg/kg, intraperitoneally) and atomoxetine hydrochloride (3 mg/kg, intraperitoneally) administered subchronically to CD-1 outbred mice. Two subpopulations of rodents differed spontaneously in attention to enriched compartments (ED-Low and ED-High), were estimated on the basis of time spent by the mice in the empty or enriched compartments. The ED-Low and ED-High mice insignificantly differed in parameters associated with anxiety, exploratory efficacy and motor activity. Subchronic administration of both drugs in selected doses produced corrective effect on animal behavior seen as a selective increase in the ED-ratio values in the ED-Low subpopulation. Differences in the distribution of dopamine D2 and GABAB receptors (Bmax) between placebo-treated ED-Low and ED-High mice were found in the prefrontal cortex using the radioligand binding method. The neuroreceptor effects of atomoxetine were seen in prefrontal cortex of ED-Low mice as decrease in the Bmax values of D2 receptors by 14%. Pantogam in the prefrontal cortex of ED-Low subpopulation showed a decrease in the Bmax values of D2 receptors by 22% and an increase for GABAB receptors by 44%. Therefore, subchronic administration of pantogam had a positive corrective effect on the behavior parameters and the density of the studied receptor subtypes in animals with severe attention deficit.
|
Authors | G I Kovalev, N A Sukhorukova, E V Vasileva, E A Kondrakhin, R M Salimov |
Journal | Biomeditsinskaia khimiia
(Biomed Khim)
Vol. 67
Issue 5
Pg. 402-410
(Sep 2021)
ISSN: 2310-6972 [Print] Russia (Federation) |
Vernacular Title | Vliianie pantogama i atomoksetina na ustoĭchivost' vnimaniia i raspredelenie dofaminovykh D2 i GAMKV-retseptorov u mysheĭ s model'iu defitsita vnimaniia. |
PMID | 34730553
(Publication Type: Journal Article)
|
Chemical References |
- pantogab
- Pantothenic Acid
- gamma-Aminobutyric Acid
- Atomoxetine Hydrochloride
- Dopamine
|
Topics |
- Animals
- Atomoxetine Hydrochloride
(pharmacology)
- Attention Deficit Disorder with Hyperactivity
(drug therapy)
- Dopamine
- Mice
- Pantothenic Acid
(analogs & derivatives)
- gamma-Aminobutyric Acid
(analogs & derivatives)
|